Non-profitUnited Statesbrightfocus.org
None yet. When a new project in the record names BrightFocus Foundation as owner, partner or investor, it shows here.
First continuous‑delivery ranibizumab implant for nAMD receives CHMP backing; designed to maintain vision with as few as two refills per year versus monthly injections.
